The Biden administration on late Friday released the unredacted exchange between federal authorities recommending marijuana be rescheduled.
“After assessing all available preclinical, clinical and epidemiological data, FDA recommends that marijuana be rescheduled from Schedule I into Schedule III of the CSA,” the Department of Health and Human Services wrote to the Drug Enforcement Administration.
ADVERTISEMENT
“Schedule III drugs are classified as having a potential for abuse less than the drugs or other substances in (Schedules) I and II, a currently accepted medical use in treatment in the United States, and moderate or low physical dependence or high psychological dependence that may result from their use,” according to the recommendation.
The National Institute on Drug Abuse “concurs with this recommendation,” the letter added.
The U.S. cannabis
Read full article on Marijuana Business Daily
